SFL’s CEO invited to speak on disruptive healthcare technologies at the Swiss HLG Winter Conference
SFL’s CEO, Shayesteh Fürst-Ladani, is presenting on “Regulating tomorrow’s healthcare technologies: promoting innovation and patient access while maintaining consumer safety and privacy” at the Swiss Healthcare Licensing Group 2020 Winter Conference (2-4 February 2020, Flüeli-Ranf, Obwalden). The presentation provides insights into regulatory frameworks for products utilizing cells and genes, medicinal products, medical devices, and related consumer privacy and data protections.
Shayesteh is an expert on innovative medical devices, pharmaceuticals and associated regulations. She holds positions as President of the Medtech & Pharma Platform, is a member of the expert group of the BIOPÔLE Digital Health Hub (DH2), and is a special coach for the Swiss Innovation Agency, Innosuisse. She also recently published an article on regulatory approval of software and digital healthcare devices with members of the SFL Medical Devices team.
Shayesteh would be happy to meet with you at the conference, or you can contact SFL to arrange a call to discuss how SFL’s expert service areas, including Regulatory Affairs, Medical Affairs and Market Access, can support you in developing and placing your innovative health ideas and new technologies onto the market.